What one share of Lisata Therapeutics holds
Lisata Therapeutics, Inc. (together with its subsidiaries, the “Company”) is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other serious diseases.
Lisata Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.01 |
|---|---|
| Profit | −$1.64 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.38 |
| Cash and investments | $1.15 |
| Book value | $0.90 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | — | −$690.00 | — | — | — | $1,137 |
| 2011 | — | −$810.00 | $9.75 | −$364.58 | — | $850.99 |
| 2012 | — | −$600.00 | $5.76 | −$156.03 | — | $303.90 |
| 2013 | — | −$285.00 | $19.68 | −$217.82 | — | $344.95 |
| 2014 | — | −$252.00 | $16.80 | −$232.16 | — | $238.62 |
| 2015 | — | −$250.05 | $9.85 | −$131.21 | — | $62.70 |
| 2016 | — | −$74.81 | $2.52 | −$56.73 | — | $8.93 |
| 2017 | — | $38.43 | $0.23 | −$35.14 | — | $79.88 |
| 2018 | — | −$25.03 | $0.21 | −$31.15 | — | $57.36 |
| 2019 | — | −$28.13 | $0.00 | −$27.43 | — | $29.69 |
| 2020 | — | −$7.92 | $0.02 | −$8.59 | — | $25.15 |
| 2021 | — | −$7.45 | $0.02 | −$6.05 | — | $23.14 |
| 2022 | — | −$10.47 | $0.06 | −$4.14 | — | $8.46 |
| 2023 | — | −$2.58 | $0.00 | −$2.48 | — | $5.91 |
| 2024 | $0.12 | −$2.40 | $0.00 | −$2.32 | — | $3.52 |
| 2025 | $0.02 | −$1.91 | $0.00 | −$1.84 | — | $1.68 |
Common questions about Lisata Therapeutics
How much does one share of Lisata Therapeutics earn?
Over the last 12 months, Lisata Therapeutics lost $1.64 for each share on $0.01 of sales.
Does Lisata Therapeutics pay a dividend?
Lisata Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Lisata Therapeutics’s book value per share?
Lisata Therapeutics’s book value is $0.90 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Lisata Therapeutics have?
Each share of Lisata Therapeutics has $1.15 of cash and investments, as of June 30, 2026.
What is Lisata Therapeutics’s free cash flow per share?
−$1.38 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Lisata Therapeutics bought back shares?
Lisata Therapeutics’s share count rose about 25359% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.